4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0001193125-25-314740
Director sold 93,445 shares at an average $14.65 ($1,369,324)
- Director acquired 87,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
HENRY CHRISTIAN O · Director
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-08 | Sale : show line 1 in the form 10b5-1 | −6,445 | $12.75 | $82,174 | 12,700 | D |
| 2025-12-08 | Exercise or conversion : show line 2 in the form 10b5-1 | +42,000 | $5.97 | $250,740 | 54,700 | D |
| 2025-12-08 | Sale : show line 3 in the form 10b5-1 | −42,000 | $12.75 | $535,500 | 12,700 | D |
| 2025-12-08 | Exercise or conversion : show line 4 in the form 10b5-1 | +15,000 | $3.50 | $52,500 | 27,700 | D |
| 2025-12-08 | Sale : show line 5 in the form 10b5-1 | −15,000 | $14.07 | $211,050 | 12,700 | D |
| 2025-12-08 | Exercise or conversion : show line 6 in the form 10b5-1 | +30,000 | $4.59 | $137,550 | 42,700 | D |
| 2025-12-08 | Sale : show line 7 in the form 10b5-1 | −30,000 | $18.02 | $540,600 | 12,700 | D |
| Open-market sales · 93,445 sh · avg $14.65 · $1,369,324 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-08 | Exercise or conversion : show line 8 in the form 10b5-1 Share Option (right to buy) | −42,000 | 0 | D |
| 2025-12-08 | Exercise or conversion : show line 9 in the form 10b5-1 Share Option (right to buy) | −15,000 | 6,000 | D |
| 2025-12-08 | Exercise or conversion : show line 10 in the form 10b5-1 Share Option (right to buy) | −30,000 | 15,000 | D |
Loading xslF345X05/ownership.xml…